Positive Outcomes. Positive Patient Stories®. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek. Our Vision To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.
| Website | http://www.paratekpharma.com |
| Ticker | NASDAQ:PRTK |
| Revenue | $160.3 million |
| Employees | 385 (318 on RocketReach) |
| Founded | 1996 |
| Address | 75 Park Plaza 4th Floor, Boston, Massachusetts 02116, US |
| Phone | (617) 807-6600 |
| Technologies |
JavaScript
,
HTML
,
PHP
+42 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Biopharma, Pharmaceuticals, Biotechnology, Drug Discovery, Health Care, Science and Engineering |
| Web Rank | 3 Million |
| Keywords | Pharmaceutical, Biopharmaceutical, Treatment Solutions, Drug Development, Pharmaceutical Research, Clinical Trials, Positive Outcomes, Antibiotics, Rare Diseases, Fda Approval, Drug Discovery, Medical Research, Health Solutions, Patient Care, Transformative Therapies, Innovative Medicines, Commercial Stage |
| Competitors | Roche, Pfizer, Bayer, Amgen, AstraZeneca, Novartis, AbbVie, Sanofi, GSK, Merck AH +49 more (view full list) |
Looking for a particular Paratek Pharmaceuticals employee's phone or email?
The Paratek Pharmaceuticals annual revenue was $160.3 million in 2026.
Evan Loh is the CEO of Paratek Pharmaceuticals.
318 people are employed at Paratek Pharmaceuticals.
Paratek Pharmaceuticals is based in Boston, Massachusetts.